|
1
|
Cazarin JM, Coelho RG, Hecht F, Andrade BM
and Carvalho DP: 5′-AMP-activated protein kinase regulates
papillary (TPC-1 and BCPAP) thyroid cancer cell survival,
migration, invasion, and epithelial-to-mesenchymal transition.
Thyroid. 26:933–942. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zou J, Hong L, Luo C, Li Z, Zhu Y, Huang
T, Zhang Y, Yuan H, Hu Y, Wen T, et al: Metformin inhibits
estrogen-dependent endometrial cancer cell growth by activating the
AMPK-FOXO1 signal pathway. Cancer Sci. 107:1806–1817. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zadra G, Photopoulos C, Tyekucheva S,
Heidari P, Weng QP, Fedele G, Liu H, Scaglia N, Priolo C, Sicinska
E, et al: A novel direct activator of AMPK inhibits prostate cancer
growth by blocking lipogenesis. EMBO Mol Med. 6:519–538. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi CH, Chung JY, Cho H, Kitano H, Chang
E, Ylaya K, Chung EJ, Kim JH and Hewitt SM: Prognostic significance
of AMP-dependent kinase alpha expression in cervical cancer.
Pathobiology. 82:203–2011. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang FY, Chiu PM, Tam KF, Kwok YK, Lau
ET, Tang MH, Ng TY, Liu VW, Cheung AN and Ngan HY:
Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on
chromosome 5 as a potential candidate cancer gene of cervical
cancer. Gynecol Oncol. 103:219–225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Laderoute KR, Calaoagan JM, Chao WR, Dinh
D, Denko N, Duellman S, Kalra J, Liu XH, Papandreou I, Sambucetti L
and Boros LG: Experimental human breast cancer supports the growth
of aggressive 5′-AMP-activated protein kinase (AMPK). J Biol Chem.
289:22850–22864. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin Y, Liu F, Fan Y, Qian X, Lang R, Gu F,
Gu J and Fu L: Both high expression of pyruvate kinase M2 and
vascular endothelial growth factor-C predicts poorer prognosis in
human breast cancer. Int J Clin Exp Pathol. 8:8028–8037.
2015.PubMed/NCBI
|
|
8
|
Yalniz Z, Tigli H, Tigli H, Sanli O, Dalay
N and Buyru N: Novel mutations and role of the LKB1 gene as a tumor
suppressor in renal cell carcinoma. Tumour Biol. 35:12361–12368.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan Y, Min SJ, Xu DQ, Shen Y, Yan HY,
Wang Y, Wang W and Tan YJ: Expressions of VEGF and miR-21 in tumor
tissues of cervical cancer patients with HPV infection and their
relationships with prognosis. Eur Rev Med Pharmacol Sci.
22:6274–6279. 2018.PubMed/NCBI
|
|
10
|
Wang F, Peng L, Wang Y and Liu X: A
Meta-analysis of vascular endothelial growth factor for
nasopharyngeal cancer prognosis. Front Oncol. 8:4862018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bagcchi S: Lung cancer survival only
increases by a small amount despite recent treatment advances.
Lancet Respir Med. 5:1692017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ettinger DS, Wood DE, Akerley W, Bazhenova
LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA,
Demmy TL, et al: Non-small cell lung cancer, version 6.2015. J Natl
Compr Canc Netw. 13:515–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu H, Zhou Y, Coughlan KA, Ding Y, Wang S,
Wu Y, Song P and Zou M: AMPKα1 deficiency promotes cellular
proliferation and DNA damage via p21 reduction in mouse
embryonic fibroblasts. Biochim Biophys Acta. 1853:65–73. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Faubert B, Boily G, Izreig S, Griss T,
Samborska B, Dong Z, Dupuy F, Chambers C, Fuerth BJ, Viollet B, et
al: AMPK is a negative regulator of the Warburg effect and
suppresses tumor growth in vivo. Cellmetab. 17:113–1124. 2013.
|
|
16
|
Zhou Y, Xu H, Ding Y, Lu Q, Zou MH and
Song P: AMPKα1 deletion in fibroblasts promotes tumorigenesis in
athymic nude mice by p52-mediated elevation of
erythropoietin and CDK2. Oncotarget. 7:53654–53667. 2016.PubMed/NCBI
|
|
17
|
Singh R, Kim WJ, Kim PH and Hong HJ:
Combined blockade of HER2 and VEGF exerts greater growth inhibition
of HER2-overexpressing gastric cancer xenografts than individual
blockade. Exp Mol Med. 45:e522013. View Article : Google Scholar : PubMed/NCBI
|
